[go: up one dir, main page]

NO20010064L - Midler med en antidepressiv virkning - Google Patents

Midler med en antidepressiv virkning

Info

Publication number
NO20010064L
NO20010064L NO20010064A NO20010064A NO20010064L NO 20010064 L NO20010064 L NO 20010064L NO 20010064 A NO20010064 A NO 20010064A NO 20010064 A NO20010064 A NO 20010064A NO 20010064 L NO20010064 L NO 20010064L
Authority
NO
Norway
Prior art keywords
drugs
antidepressant effect
antidepressant
effect
Prior art date
Application number
NO20010064A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010064D0 (no
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20010064D0 publication Critical patent/NO20010064D0/no
Publication of NO20010064L publication Critical patent/NO20010064L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010064A 1998-07-07 2001-01-05 Midler med en antidepressiv virkning NO20010064L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (fr) 1998-07-07 1999-07-02 Agent a effet antidepressif

Publications (2)

Publication Number Publication Date
NO20010064D0 NO20010064D0 (no) 2001-01-05
NO20010064L true NO20010064L (no) 2001-03-02

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010064A NO20010064L (no) 1998-07-07 2001-01-05 Midler med en antidepressiv virkning

Country Status (32)

Country Link
US (1) US6255329B1 (fr)
EP (1) EP1093369B1 (fr)
JP (1) JP2002520273A (fr)
KR (1) KR100557692B1 (fr)
CN (1) CN1230168C (fr)
AR (1) AR019896A1 (fr)
AT (1) ATE228365T1 (fr)
AU (1) AU762128B2 (fr)
BG (1) BG64972B1 (fr)
BR (1) BR9911768A (fr)
CA (1) CA2336833C (fr)
CZ (1) CZ294087B6 (fr)
DE (2) DE19830201A1 (fr)
DK (1) DK1093369T3 (fr)
EA (1) EA003142B1 (fr)
EE (1) EE04296B1 (fr)
ES (1) ES2183583T3 (fr)
HU (1) HUP0103922A3 (fr)
ID (1) ID27776A (fr)
IL (1) IL140603A0 (fr)
MY (1) MY117969A (fr)
NO (1) NO20010064L (fr)
NZ (1) NZ509729A (fr)
PL (1) PL195043B1 (fr)
PT (1) PT1093369E (fr)
RS (1) RS49795B (fr)
SK (1) SK284923B6 (fr)
TR (1) TR200100146T2 (fr)
TW (1) TW592698B (fr)
WO (1) WO2000002542A2 (fr)
YU (1) YU401A (fr)
ZA (1) ZA200100090B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (fr) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Agents a effet antidepresseur, comprenant du pramipexol et un autre antidepresseur
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
AU2002360600B2 (en) * 2001-12-11 2007-11-29 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
JP2007518754A (ja) * 2004-01-22 2007-07-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング モノアミン神経伝達物質再取込みインヒビターとドーパミンアゴニストを含む医薬組成物
CA2619217A1 (fr) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestauration avec du pramipexole r(+)
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ES2379117T3 (es) 2006-05-16 2012-04-20 Knopp Neurosciences, Inc. Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
EP2137171A4 (fr) 2007-03-14 2010-05-19 Knopp Neurosciences Inc Synthèse de benzothiazole diamines substituées et purifiées du point de vue chiral
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CA2734491A1 (fr) * 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions et procedes employant du (r)-pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
CA2760527A1 (fr) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Procede de traitement d'une depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
CA2864088C (fr) 2012-02-08 2020-04-28 Supernus Pharmaceuticals, Inc. Formulations a liberation modifiee de viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
WO2015023786A1 (fr) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions et méthodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires à cellules b
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
ES3009607T3 (en) 2017-06-30 2025-03-27 Chase Therapeutics Corp Nk-1 antagonist compositions and methods for use in treating depression
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (fr) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
CA2273809A1 (fr) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Utilisation d'antagonistes du recepteur nk-1 dans le traitement des diskynesies
CA2318095C (fr) * 1998-01-13 2012-11-20 Barry S. Fogel Methodes de traitement de la dyskinesie tardive et autres perturbations des mouvements

Also Published As

Publication number Publication date
ATE228365T1 (de) 2002-12-15
AU762128B2 (en) 2003-06-19
PL345842A1 (en) 2002-01-14
YU401A (sh) 2003-10-31
ES2183583T3 (es) 2003-03-16
HUP0103922A3 (en) 2002-08-28
NO20010064D0 (no) 2001-01-05
ID27776A (id) 2001-04-26
BR9911768A (pt) 2001-04-03
CZ200177A3 (en) 2001-06-13
TW592698B (en) 2004-06-21
RS49795B (sr) 2008-06-05
EE04296B1 (et) 2004-06-15
SK284923B6 (sk) 2006-02-02
HK1037976A1 (en) 2002-03-01
NZ509729A (en) 2003-06-30
EA200100084A1 (ru) 2001-08-27
SK112001A3 (en) 2001-10-08
HUP0103922A2 (hu) 2002-03-28
CN1230168C (zh) 2005-12-07
US6255329B1 (en) 2001-07-03
EA003142B1 (ru) 2003-02-27
BG105112A (bg) 2001-10-31
MY117969A (en) 2004-08-30
KR20010079491A (ko) 2001-08-22
TR200100146T2 (tr) 2001-07-23
KR100557692B1 (ko) 2006-03-07
IL140603A0 (en) 2002-02-10
CZ294087B6 (cs) 2004-10-13
PL195043B1 (pl) 2007-08-31
JP2002520273A (ja) 2002-07-09
ZA200100090B (en) 2002-04-04
AU5030399A (en) 2000-02-01
CA2336833A1 (fr) 2000-01-20
BG64972B1 (bg) 2006-11-30
CN1308533A (zh) 2001-08-15
DE19830201A1 (de) 2000-01-13
CA2336833C (fr) 2008-09-23
EP1093369B1 (fr) 2002-11-27
WO2000002542A2 (fr) 2000-01-20
DE59903556D1 (de) 2003-01-09
DK1093369T3 (da) 2002-12-16
PT1093369E (pt) 2003-03-31
EP1093369A2 (fr) 2001-04-25
AR019896A1 (es) 2002-03-20
WO2000002542A3 (fr) 2000-06-22
EE200100014A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
NO20010064L (no) Midler med en antidepressiv virkning
ID23338A (id) Popok tarik sekali pakai
NO20003640D0 (no) Ny doseringsform
ID26974A (id) Ketoenol siklik arilfenil-tersubstitusi
NO2008014I2 (no) Rotigotin
IS5760A (is) Meðferðarlegar bíarýl afleiður
NO984956D0 (no) Brenner
FI991485A0 (fi) Uusi farmaseuttinen koostumus
DE69922494D1 (de) Zyklische n-acylamin-derivate
NO20005913D0 (no) Legemiddelsammensetning
ID26162A (id) Turunan-turunan benzilbifenil biosida
NO20010046D0 (no) Dolastatin-15-derivater
ATE236136T1 (de) Benzosulfonderivate
ID29089A (id) Sediaan farmasi moksifloksasin
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
DE69919784D1 (de) Spritze
ID23198A (id) Popok tarik sekali pakai
NO992692D0 (no) Nefadozon doseringsform
DK1466615T3 (da) Farmaceutisk præparat
DK1056448T3 (da) Farmaceutiske kombinationer med tramadol
NO20000746D0 (no) Brenner
FR2774599B1 (fr) Cataplasme
DE69921275D1 (de) Inhalationsgerät
ATE233253T1 (de) Chromanderivate
IS6163A (is) Lyfjakomplex

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application